HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹533 Cr | ₹643 Cr | ₹590 Cr | ₹432 Cr | ₹379 Cr |
What is the latest Total Non-Current Liabilities ratio of HIKAL ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹533 Cr |
| Mar2024 | ₹643 Cr |
| Mar2023 | ₹590 Cr |
| Mar2022 | ₹432 Cr |
| Mar2021 | ₹379 Cr |
How is Total Non-Current Liabilities of HIKAL Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹533 Cr | -17.09 | |
| Mar2024 | ₹643 Cr | 8.90 | |
| Mar2023 | ₹590 Cr | 36.71 | |
| Mar2022 | ₹432 Cr | 13.96 | |
| Mar2021 | ₹379 Cr | - | |
Compare Total Non-Current Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,712.6 Cr | -0.6% | 14.7% | -38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.6% |
14.7% |
-38.8% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses